TY - JOUR
T1 - Rapid Visualization of Deeply Located Tumors in Vivo by Intravenous Administration of a γ-Glutamyltranspeptidase-Activated Fluorescent Probe
AU - Nakada, Akihiro
AU - Maruyama, Takuma
AU - Kamiya, Mako
AU - Hanaoka, Kenjiro
AU - Urano, Yasuteru
N1 - Funding Information:
We thank Mr. Yokobata, Toxicology Research Laboratory, Watarase Research Center, Discovery Research Headquarters, Kyorin Pharmaceutical Co., Ltd, for assistance with the toxicity study. This research was supported in part by a JST grant (Moonshot R&D–MILLENNIA Program, JPMJMS2022–12) (to Y.U.), MEXT/JSPS KAKENHI grant JP19H05632 (to Y.U.), and the JSPS Core-to-Core Program (grant no. JPJSCCA20170007), A. Advanced Research Networks.
Publisher Copyright:
© 2022 American Chemical Society. All rights reserved.
PY - 2022/3/16
Y1 - 2022/3/16
N2 - We previously showed that spraying the fluorescent probe gGlu-HMRG (γ-glutamyl hydroxymethyl rhodamine green) can visualize even tiny tumors on the mesentery and peritoneal wall of tumor-bearing mice. However, during surgery, repeated spraying is necessary to detect tumors located deep within organs. Here, we examine whether deeply located tumors can be stained by intravenous administration of this probe. In mice bearing subcutaneous tumors, intravenous administration of gGlu-HMRG resulted in a rapid and specific increase of fluorescence in the tumor, which was visible to the naked eye within 5 min, and the maximum fluorescence intensity ratio of tumor to normal tissue (T/N = 4.3) was reached at 30 min. In mice bearing lung tumors, the T/N ratio reached approximately 20 at 30 min after administration, and deeply located tumors were clearly visualized. These results suggest that intravenous administration of gGlu-HMRG may be a useful technique in fluorescence-guided surgery of tumors.
AB - We previously showed that spraying the fluorescent probe gGlu-HMRG (γ-glutamyl hydroxymethyl rhodamine green) can visualize even tiny tumors on the mesentery and peritoneal wall of tumor-bearing mice. However, during surgery, repeated spraying is necessary to detect tumors located deep within organs. Here, we examine whether deeply located tumors can be stained by intravenous administration of this probe. In mice bearing subcutaneous tumors, intravenous administration of gGlu-HMRG resulted in a rapid and specific increase of fluorescence in the tumor, which was visible to the naked eye within 5 min, and the maximum fluorescence intensity ratio of tumor to normal tissue (T/N = 4.3) was reached at 30 min. In mice bearing lung tumors, the T/N ratio reached approximately 20 at 30 min after administration, and deeply located tumors were clearly visualized. These results suggest that intravenous administration of gGlu-HMRG may be a useful technique in fluorescence-guided surgery of tumors.
UR - http://www.scopus.com/inward/record.url?scp=85125127665&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125127665&partnerID=8YFLogxK
U2 - 10.1021/acs.bioconjchem.2c00039
DO - 10.1021/acs.bioconjchem.2c00039
M3 - Article
C2 - 35166539
AN - SCOPUS:85125127665
SN - 1043-1802
VL - 33
SP - 523
EP - 529
JO - Bioconjugate Chemistry
JF - Bioconjugate Chemistry
IS - 3
ER -